| Zugriffe | |
|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 456 |
| Juni 2025 | Juli 2025 | August 2025 | September 2025 | Oktober 2025 | November 2025 | Dezember 2025 | |
|---|---|---|---|---|---|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 11 | 19 | 8 | 9 | 29 | 16 | 11 |
| Zugriffe | |
|---|---|
| 3_Chapter3_Materials_Methods.pdf | 353 |
| 6_Chapter6_References.pdf | 304 |
| 1_Chapter1_Introduction_aims_objectives.pdf | 233 |
| 0_Title_Index.pdf | 219 |
| 7_Chapter7_Appendices_Aknowledgements.pdf | 203 |
| 4_Chapter4_Results_Discussions.pdf | 173 |
| 2_Chapter2_Literature_review.pdf | 163 |
| 5_Chapter5_Summary_Zusammenfassung.pdf | 115 |
